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control group (P <0.05), but no significant difference was found between the two groups (P <0.05). ④ The Karnofsky score of the experimental group was significantly higher than that of the control group (P <0.05). Conclusion: Chinese medicine combined with transcatheter arterial chemoembolization in patients with primary liver cancer in the application value is relatively high.
Introduction
Hepatocellular carcinoma, the most common in primary liver cancer, is more malignant and ranks the second in the mortality of malignant tumor [1] [2] .
Treatment of patients with primary liver cancer is mainly surgical resection, but because of its inapparent early clinical symptoms, once the diagnosis has reached the middle and late stage, many patients may lose the chance of surgery [3] [4] . With the extensive application of transcatheter arterial chemoembolization (TACE), transcatheter arterial chemoembolization has become the first choice for non-surgical treatment of primary hepatocellular carcinoma (HCC). However, only non-operation of transcatheter arterial chemoembolization can cause adverse reactions such as acute hepatic failure and liver damage and jaundice, even reduce the quality of life of patients with primary liver cancer [5] [6] . According to the relevant work experience, the author will analyze the application of Chinese medicine combined with transcatheter arterial chemoembolization in patients with primary liver cancer and its effect on liver function. Details are reported below. 
Materials and methods

Clinical Material
Observation indicators
Analyze the short-term effect, follow-up of one-year primary liver cancer recurrence rate, before and after treatment WBC count, liver function (alanine aminotransferase), alpha-fetoprotein and Karnofsky index parameters and other indicators of patients in two groups.
Assess indicators of short-term effect
Complete remission [7] ：After treatment, the lesions in patients with primary liver cancer were completely absorbed ； partial remission ： After treatment, the multiplication of the maximum diameter of the tumor and the vertical diameter is reduced by more than 50%
compared to the number before treatment; Stable:
After receiving treatment, the lesion of primary liver cancer patients decreased, and the increase of size is less than 25%; progress: After treatment, the tumor lesions in patients with primary hepatocellular carcinoma were enlarged by 30% compared to the situation before treatment.
Karnofsky index parameters (total 100): patients get 80
to 100 points can act normally, with mild clinical symptoms; patients get 60 to 79 points can take care of themselves and need help sometimes； patients get 10 to 59 points cannot take care of themselves and need hospitalization.
Statistical method
The data obtained from this subject are SPSS12.0 statistical software. ( x ±s) is used to express measurement data. T-Test is used to compare the difference between and within groups. χ 2 is used to test the difference. When P< 0.05, the difference is considered statistically significant. 
Results
Comparison of operation situations between the two groups
Comparison of recurrence rate after one-year follow-up in two groups of patients
The follow-up of one year primary liver cancer recurrence rate in the experimental group is 19.67% (12/61)，and the observation group 54.10%(33/61) .
The relapse rate of the experimental group was significantly lower than that of the control group，and there's statistic significance in data of two groups(P＜ 0.05＝. 
Comparison of before and after treatment white blood cell count, liver function and alpha-fetoprotein levels in two groups of patients
Comparison of Karnofsky index parameters in two groups of patients
Discussion
Primary hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China, with higher morbidity and mortality [8] [9] . The primary method of treating primary liver cancer is interventional therapy, and has significant treatment effect especially for patients with advanced hepatocellular carcinoma.
However, there are still some defects in the interventional therapy. For example, immune function inhibition, tumor biological behavior and liver function impairment in interventional therapy will affect the quality of life and prognosis of patients [10] [11] . In general, patients with primary hepatocellular carcinoma have poor prognosis and short survival time, so it is the focus of attention to provide appropriate methods for treatment. The transcatheter arterial chemoembolization is one of the most important methods in treating primary liver cancer patients at the present stage, and its main advantages are as follows:
first, high safety; second, good effect; third, easy to repeat; four, little trauma [12] [13] . The results of this study showed that the total effective rate of treatment in the experimental group was 81.97%, the total effective rate of the control group was 52.46%, and the curative effect of the patients in the experimental group was much higher than that of the control group (P＜0.05＝; The recurrence rate of patients after one-year follow-up was 19.67%, and the recurrence rate of the control group was 54.1%, and the recurrence rate in the experimental group was much lower than that in the control group(P＜0.05＝. cancer is of high value, and it is worth popularizing [14] [15] .
